|

Venetoclax 100 mg d1，200 mg d2，400 mg d3-28； Clinical Trials

1 actively recruiting trial

Also known as: AZA 75mg/m2 on days 1-7, G-CSF: 50-600ug/day, starting on day 1 (adjusted based on WBC count of 10-25*10E9/L)

Top Sponsors

  • Yang Xiaotian1

Indications

  • Acute Myeloid Leukemia1
  • Cancer1

Other1 trial

Clinical Trial Protocol for the Combined Use of VAG in the Treatment of ND-AML
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.